Drug Discovery

Science News

Use of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes in Preclinical Cancer Drug Cardiotoxicity Testing
Establishment of Specialized Clinical Cardiovascular Genetics Programs Recognizing Standards
2019 CVD Primary Prevention Guideline
2018 Guideline on the Management of Blood Cholesterol
AHA/ACC Special Report: Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease (ASCVD)

Continuing Education

Registration Now Open

Mark your calendars now to experience the premier global event focusing on improving health by championing scientific discovery and practice-changing educational content.

We can't wait to see you this November! Even though #AHA21 was fully virtual, our flagship meeting brought us together across the globe. If you missed some of our great programming, now is your chance!

Members can now access informative, practice-changing sessions or earn CE credits for free through a different link. And nonmembers can still purchase our Sessions package or our special CE bundle.

The ATVB Council focuses on arteriosclerosis, thrombosis and vascular biology. The council advances research, addresses prevention, improves diagnosis and treatment, and works actively with other organizations. It shares reliable information through its annual conference, awards and lectures, and in the AHA’s journal, Arteriosclerosis, Thrombosis, and Vascular Biology.


The CLCD Council supports AHA objectives in clinical cardiology, promotes excellent clinical care, and fosters professional development and education for clinical cardiologists. Through council-sponsored symposia, panels, and scientific conferences, members can access and interpret new developments in the field and promote clinical cardiology to professional and lay audiences.


The GPM Council seeks to advance discovery and translation of biological insights from genetics and omics technologies to improve cardiovascular and brain health through better risk prediction, treatment and prevention for patients. Our expertise spans genetics, genomics, genomic medicine, epigenetics, transcriptomics, metabolomics, proteomics, microbiome, bioinformatics, computational science, and population health.


TIPS 3 Results

Principal investigator Prem Pais, MD summarizes the results of TIPS-3, which tested the use of a polypill for primary prevention of cardiovascular disease.

American Heart Association Professional Members

Enjoy instant benefits!

  • Free Online Access to AHA Scientific Journals
  • Affiliate with our 16 Scientific Councils
  • Discounts on Scientific Conference Registration and Online Courses